CLINICAL STUDIES
Renal ischemia/reperfusion remotely improves myocardial energy metabolism during myocardial ischemia via adenosine receptors in rabbits: effects of "remote preconditioning"
Atsushi Takaoka, MDa,
Ichiro Nakae, MD, PhDa,
Kenichi Mitsunami, MD, PhD*,
Takahiro Yabe, MD, PhDa,
Shigehiro Morikawa, MD, PhD ,
Toshiro Inubushi, PhD and
Masahiko Kinoshita, MD, PhDa
a First Department of Internal Medicine, Shiga University of Medical Science, Seta, Otsu 520-2192, Japan
* Department of General Medicine, Medical Coordination Center, Shiga University of Medical Science, Seta, Otsu 520-2192, Japan
Molecular Neurobiology Research Center, Shiga University of Medical Science, Seta, Otsu 520-2192, Japan
Manuscript received May 19, 1998;
revised manuscript received September 1, 1998,
accepted October 2, 1998.
Reprint requests and correspondence: Dr. Atsushi Takaoka, First Department of Internal Medicine, Shiga University of Medical Science, Seta, Otsu 520-2192, Japan taka5836{at}belle.shiga-med.ac.jp
Objectives
This study examined the changes in myocardial energy metabolism during myocardial ischemia after "remote preconditioning" and investigated the involvement of adenosine receptors in the mechanisms of this effect.
Background
Recent studies have indicated that a brief period of ischemia and reperfusion (ischemic preconditioning, PC) in a remote organ reduces myocardial infarct size (IS) protecting against subsequent sustained myocardial ischemia. However, the mechanisms of "remote PC" remain unclear. We assessed myocardial energy metabolism during sustained myocardial ischemia and reperfusion after renal PC (RPC), in comparison with that after myocardial PC (MPC) in open-chest rabbits. It has been established that adenosine receptors are involved in the mechanisms of MPC.
Methods
Rabbits that had been anesthetized with halothane were divided into six groups. The control (CNT) group underwent 40-min coronary occlusion followed by 120 min reperfusion. Before the procedure, the MPC group underwent an additional protocol of 5 min coronary artery occlusion and 20 min reperfusion, and the RPC group received a 10 min episode of renal artery occlusion and 20 min reperfusion. In additional experimental groups, 8 sulfophenyltheophylline (SPT, 10 mg/kg), an adenosine receptor inhibitor, was intravenously injected before the 40 min myocardial ischemia (SPT, MPC + SPT and RPC + SPT groups, respectively). Myocardial levels of phosphocreatine (PCr), ATP and intracellular pH (pHi) were measured by 31P-NMR spectroscopy.
Results
RPC and MPC delayed the decreases in ATP levels, preserved pHi during 40-min myocardial ischemia and resulted in better recovery of ATP and PCr during 120 min reperfusion compared with the controls. SPT abolished the improvement in myocardial energy metabolism and the reduction in myocardial IS caused by MPC or RPC. Myocardial IS in the CNT (n = 8), MPC (n = 9), RPC (n = 9), SPT (n = 6), MPC + SPT (n = 8) and RPC + SPT (n = 8) groups averaged 42.8 ± 3.5%, 18.2 ± 1.8%*, 19.6 ± 1.3%*, 44.9 ± 5.0%, 35.6 ± 2.7% and 34.8 ± 3.6% of the area at risk (*p < 0.05 vs. CNT), respectively.
Conclusions
PC in a remote organ, similar to MPC, improved myocardial energy metabolism during ischemia and reperfusion and reduced IS in vivo by an adenosine-dependent mechanism in rabbits.
|
Abbreviations and Acronyms
| | AAR | = area at risk | | CNT | = control | | 2,3-DPG | = 2, 3-diphosphoglyceric acid | | IS | = infarct size | | MPC | = myocardial ischemic preconditioning | | PC | = ischemic preconditioning | | PCr | = phosphocreatine | | pHi | = intracellular pH | | RPC | = renal ischemic preconditioning | | SPT | = 8-sulfophenyltheophylline |
|
This article has been cited by other articles:

|
 |

|
 |
 
H. L. Lujan and S. E. DiCarlo
Partial Hindlimb Occlusion Reduced the Susceptibility to Sustained Ventricular Tachycardia in Conscious Rats
Journal of Cardiovascular Pharmacology and Therapeutics,
September 1, 2009;
14(3):
199 - 206.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Hausenloy and D. M. Yellon
Remote ischaemic preconditioning: underlying mechanisms and clinical application
Cardiovasc Res,
August 1, 2008;
79(3):
377 - 386.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. R. Walsh, T. Tang, U. Sadat, D. P. Dutka, and M. E. Gaunt
Cardioprotection by remote ischaemic preconditioning
Br. J. Anaesth.,
November 1, 2007;
99(5):
611 - 616.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. P. Loukogeorgakis, R. Williams, A. T. Panagiotidou, S. K. Kolvekar, A. Donald, T. J. Cole, D. M. Yellon, J. E. Deanfield, and R. J. MacAllister
Transient Limb Ischemia Induces Remote Preconditioning and Remote Postconditioning in Humans by a KATP Channel Dependent Mechanism
Circulation,
September 18, 2007;
116(12):
1386 - 1395.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Ramzy, V. Rao, and R. D. Weisel
Clinical applicability of preconditioning and postconditioning: The cardiothoracic surgeons's view
Cardiovasc Res,
May 1, 2006;
70(2):
174 - 180.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. J. Gross
Remote preconditioning and delayed cardioprotection in skeletal muscle
Am J Physiol Regulatory Integrative Comp Physiol,
December 1, 2005;
289(6):
R1562 - R1563.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Moses, P. D. Addison, P. C. Neligan, H. Ashrafpour, N. Huang, S. E. McAllister, J. E. Lipa, C. R. Forrest, and C. Y. Pang
Inducing late phase of infarct protection in skeletal muscle by remote preconditioning: efficacy and mechanism
Am J Physiol Regulatory Integrative Comp Physiol,
December 1, 2005;
289(6):
R1609 - R1617.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Loubani, A. Hassouna, and M. Galinanes
Delayed preconditioning of the human myocardium: signal transduction and clinical implications
Cardiovasc Res,
February 15, 2004;
61(3):
600 - 609.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Nishino, T. Miura, T. Miki, J. Sakamoto, Y. Nakamura, Y. Ikeda, H. Kobayashi, and K. Shimamoto
Ischemic preconditioning activates AMPK in a PKC-dependent manner and induces GLUT4 up-regulation in the late phase of cardioprotection
Cardiovasc Res,
February 15, 2004;
61(3):
610 - 619.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Vaage and G. Valen
Preconditioning and cardiac surgery
Ann. Thorac. Surg.,
February 1, 2003;
75(2):
S709 - 714.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Liem, P. D. Verdouw, H. Ploeg, S. Kazim, and D. J. Duncker
Sites of action of adenosine in interorgan preconditioning of the heart
Am J Physiol Heart Circ Physiol,
July 1, 2002;
283(1):
H29 - H37.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Tokuno, K. Hinokiyama, K. Tokuno, C. Lowbeer, L.-O. Hansson, and G. Valen
Spontaneous Ischemic Events in the Brain and Heart Adapt the Hearts of Severely Atherosclerotic Mice to Ischemia
Arterioscler Thromb Vasc Biol,
June 1, 2002;
22(6):
995 - 1001.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Mubagwa and W. Flameng
Adenosine, adenosine receptors and myocardial protection: An updated overview
Cardiovasc Res,
October 1, 2001;
52(1):
25 - 39.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Li, S. Chen, E. Lu, and W. Luo
Cardiac ischemic preconditioning improves lung preservation in valve replacement operations
Ann. Thorac. Surg.,
February 1, 2001;
71(2):
631 - 635.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. T.F. Cheung, M. Weih, and U. Dirnagl
Ischemic Preconditioning and Tolerance in Human Brain Response
Stroke,
September 1, 2000;
31
(9):
2266 - 2278.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. G. Schoemaker and C. L. van Heijningen
Bradykinin mediates cardiac preconditioning at a distance
Am J Physiol Heart Circ Physiol,
May 1, 2000;
278(5):
H1571 - H1576.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|